NCT03717688View on ClinicalTrials.gov

The Effects of Neprilysin on Glucagon-like Peptide-1

PHASE4CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

May 17, 2018

Primary Completion Date

February 1, 2019

Study Completion Date

May 14, 2019

Conditions
DiabetesHeart Failure
Interventions
DRUG

Entresto

Single dose administration of Entrestro 194 mg sacubitril / 206 mg valstartan

DRUG

Sitagliptin 100mg

2 x 100mg sitagliptin as single dose.

DRUG

Placebos

No treatment

Trial Locations (1)

2100

University of Copenhagen, Copenhagen

All Listed Sponsors
lead

Nicolai Jacob Wewer Albrechtsen

OTHER

NCT03717688 - The Effects of Neprilysin on Glucagon-like Peptide-1 | Biotech Hunter | Biotech Hunter